Ecologists focused on grasslands urge policymakers to keep forestation efforts in check.

With a card game, researchers make light of the “wacky aspects of scientific research.”

Improving Zika diagnostics; genetics of schizophrenia; spermatogenesis in mice without Y chromosomes; toward animal-free toxicity testing

The National Science Foundation reiterates its commitment “to eradicate gender-based discrimination in science” with a statement geared toward the institutions it funds.

NEJM and “research parasites”; battle of the CRISPR biotechs; phage therapy in the spotlight

Historical account of CRIPSR criticized; ApoE as a transcriptional regulator; Ebola-induced human monoclonal antibodies; yeast mate in wasp guts; PubPeer’s anonymity appeal presses on

Critics have harsh words for the Broad Institute’s Eric Lander and Cell over a recent perspective piece describing the history of CRISPR.

Health officials warn pregnant women against visiting places hardest hit by the virus.

Toward predicting food allergy; effects of fiber on the gut microbiome; repeated blast exposure affects cerebellum; CRISPR patent “interference”

Guinea, Liberia, and Sierra Leone have reported no cases for at least 42 days, the World Health Organization announces.

The Dublin-based pharma giant is set to acquire Baxalta, an Illinois-based Baxter spinoff, expanding its rare disease drug portfolio.

The boards of both companies have agreed to a $1.3 billion deal, which is subject to Affymetrix shareholder approval.